Cargando…
When should surgery be used to supplement systemic therapy in metastatic renal cell cancer?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323568/ https://www.ncbi.nlm.nih.gov/pubmed/37426166 http://dx.doi.org/10.21037/jtd-23-457 |
| _version_ | 1785068975286124544 |
|---|---|
| author | Hardman, Morgan Gabriel, Emmanuel |
| author_facet | Hardman, Morgan Gabriel, Emmanuel |
| author_sort | Hardman, Morgan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10323568 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103235682023-07-07 When should surgery be used to supplement systemic therapy in metastatic renal cell cancer? Hardman, Morgan Gabriel, Emmanuel J Thorac Dis Editorial AME Publishing Company 2023-06-05 2023-06-30 /pmc/articles/PMC10323568/ /pubmed/37426166 http://dx.doi.org/10.21037/jtd-23-457 Text en 2023 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Hardman, Morgan Gabriel, Emmanuel When should surgery be used to supplement systemic therapy in metastatic renal cell cancer? |
| title | When should surgery be used to supplement systemic therapy in metastatic renal cell cancer? |
| title_full | When should surgery be used to supplement systemic therapy in metastatic renal cell cancer? |
| title_fullStr | When should surgery be used to supplement systemic therapy in metastatic renal cell cancer? |
| title_full_unstemmed | When should surgery be used to supplement systemic therapy in metastatic renal cell cancer? |
| title_short | When should surgery be used to supplement systemic therapy in metastatic renal cell cancer? |
| title_sort | when should surgery be used to supplement systemic therapy in metastatic renal cell cancer? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323568/ https://www.ncbi.nlm.nih.gov/pubmed/37426166 http://dx.doi.org/10.21037/jtd-23-457 |
| work_keys_str_mv | AT hardmanmorgan whenshouldsurgerybeusedtosupplementsystemictherapyinmetastaticrenalcellcancer AT gabrielemmanuel whenshouldsurgerybeusedtosupplementsystemictherapyinmetastaticrenalcellcancer |